Reducing MRSA infections after cardiacthoracic surgery

In this single center prospective cohort, patients undergoing cardiothoracicsurgery were all givennasal mupirocin decolonization (for 5 days preop), and prophylactic pre-operative vancomycin (if they were MRSA nasal carriers), and mupirocin to all chest tube sites after withdrawal. The rate of MRSA wound infections decreased 93% from before to after the intervention (with no institutional change in the rate of MRSA infections among non-cardiothoracic patients). This 3 tiered MRSA eradication intervention in cardiothoracic surgery patients can reduce the risk of MRSA post op infections (abstract)

Danielle Scheurer

Dr. Scheurer is a clinical hospitalist and the Medical Director of Quality and Safety at the Medical University of South Carolina in Charleston, South Carolina, and is Assistant Professor of Medicine. She is a graduate of the University of Tennessee College of Medicine, completed her residency at Duke University, and completed her Masters in Clinical Research at the Medical University of South Carolina. She also serves as the Web Editor and Physician Advisor for the Society of Hospital Medicine.

Leave a Comment